Cargando…

DR2 blocker thioridazine: A promising drug for ovarian cancer therapy

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Yong, Min, Yu, Tinghe, Tian, Si, Liu, Shuaibin, Xu, Jiao, Hu, Jianguo, Hu, Lina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039101/ https://www.ncbi.nlm.nih.gov/pubmed/32194705 http://dx.doi.org/10.3892/ol.2020.11285

Ejemplares similares

DR2 blocker thioridazine: A promising drug for ovarian cancer therapy
por: Yong, Min, et al.
Publicado: (2020)

Thioridazine Enhances Cisplatin-Induced DNA Damage in Cisplatin-Resistant Human Lung Cancer Cells
por: Luo, Yuanyuan, et al.
Publicado: (2022)

Effect of Thioridazine on Erythrocytes
por: Lang, Elisabeth, et al.
Publicado: (2013)

Tyrosine kinase LYN is an oncotarget in human cervical cancer: A quantitative proteomic based study
por: Liu, Shuaibin, et al.
Publicado: (2016)

Ubiquitin E3 ligase MARCH7 promotes ovarian tumor growth
por: Hu, Jianguo, et al.
Publicado: (2015)

Combining thioridazine and loratadine for the treatment of gastrointestinal tumor
por: Chen, Tingting, et al.
Publicado: (2017)

Targeting Lung Cancer Stem Cells with Antipsychological Drug Thioridazine
por: Yue, Haiying, et al.
Publicado: (2016)

The Antipsychotic Thioridazine Shows Promising Therapeutic Activity in a Mouse Model of Multidrug-Resistant Tuberculosis
por: van Soolingen, Dick, et al.
Publicado: (2010)

Silencing MARCH1 suppresses proliferation, migration and invasion of ovarian cancer SKOV3 cells via downregulation of NF-κB and Wnt/β-catenin pathways
por: Meng, Ying, et al.
Publicado: (2016)

Corrigendum to “Cell therapies in ovarian cancer”
Publicado: (2021)

Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
por: Jin, Xun, et al.
Publicado: (2016)

The Effect of Fluphenazine and Thioridazine on Toxoplasma gondii In Vivo
por: SARAEI, Mehrzad, et al.
Publicado: (2016)

Molecular mechanisms of thioridazine resistance in Staphylococcus aureus
por: Wassmann, Claes Søndergaard, et al.
Publicado: (2018)

Repurposing Thioridazine (TDZ) as an anti-inflammatory agent
por: Baig, Mirza S., et al.
Publicado: (2018)

Thioridazine as Chemotherapy for Mycobacterium avium Complex Diseases
por: Deshpande, Devyani, et al.
Publicado: (2016)

Clinical chimeric antigen receptor T‐cell therapy: a new and promising treatment modality for glioblastoma
por: Brown, Michael P, et al.
Publicado: (2021)

A Mycobacterium tuberculosis Sigma Factor Network Responds to Cell-Envelope Damage by the Promising Anti-Mycobacterial Thioridazine
por: Dutta, Noton K., et al.
Publicado: (2010)

Corrigendum to: ‘Mesenchymal stromal cells-exosomes: a promising cell-free therapeutic tool for wound healing and cutaneous regeneration’
por: Hu, Peng, et al.
Publicado: (2020)

METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma
por: Li, Min, et al.
Publicado: (2023)

Effect of thioridazine on antioxidant status of HEMn-DP melanocytes
por: Otręba, Michał, et al.
Publicado: (2015)

Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis
por: Lu, Meiling, et al.
Publicado: (2015)

Anti-staphylococcal activity and mode of action of thioridazine photoproducts
por: Tozar, Tatiana, et al.
Publicado: (2020)

FOXO3a-mediated suppression of the self-renewal capacity of sphere-forming cells derived from the ovarian cancer SKOV3 cell line by 7-difluoromethoxyl-5,4’-di-n-octyl genistein
por: Ning, Yingxia, et al.
Publicado: (2021)

Correction to: Dong et al., Promising galactose-decorated biodegradable poloxamer 188-PLGA diblock copolymer nanoparticles of resibufogenin for enhancing liver cancer therapy
Publicado: (2017)

WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability
por: Zhang, Minghui, et al.
Publicado: (2018)

Clinical and biological effects of tumor associated lymphocytes in the presence or absence of chemotherapy for malignant ascites in ovarian cancer patients
por: Zhang, Weiwei, et al.
Publicado: (2018)

EMSAM (deprenyl patch): how a promising antidepressant was underutilized [Corrigendum]
Publicado: (2014)

The macrolide drug erythromycin does not protect the hERG channel from inhibition by thioridazine and terfenadine
por: El Harchi, Aziza, et al.
Publicado: (2020)

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era [Corrigendum]
Publicado: (2015)

Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer
por: Kim, Se-Lim, et al.
Publicado: (2019)

Corrigendum to “Kuntai Capsule plus Hormone Therapy vs. Hormone Therapy Alone in Patients with Premature Ovarian Failure: A Systematic Review and Meta-Analysis”
por: Liu, Weiping, et al.
Publicado: (2021)

Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise
por: Trivedi, Palak J, et al.
Publicado: (2018)

Correction to ‘DrugCombDB: a comprehensive database of drug combinations toward the discovery of combinatorial therapy’
por: Liu, Hui, et al.
Publicado: (2021)

Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium
por: Pearce, C L, et al.
Publicado: (2009)

High Molecular Weight Hyaluronic Acid Inhibits Fibrosis of Endometrium
por: Zhu, Yi, et al.
Publicado: (2016)

Corrigendum to “Potential of Gene and Cell Therapy for Inner Ear Hair Cells”
por: Lee, Min Young, et al.
Publicado: (2019)

Effect of hyperbaric oxygenation therapy on post-concussion syndrome
por: Dong, Yan, et al.
Publicado: (2018)

Corrigendum to “The Protective Effect of N-Acetylcysteine on Ionizing Radiation Induced Ovarian Failure and Loss of Ovarian Reserve in Female Mouse”
por: Gao, Wei, et al.
Publicado: (2021)

Pediatric thioridazine poisoning as a result of a pharmacy compounding error
por: Kato, Zenichiro, et al.
Publicado: (2009)

Why and How the Old Neuroleptic Thioridazine Cures the XDR-TB Patient
por: Amaral, Leonard, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_634b5c20fmjad5i9moprdd61be